Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) CFO Sells 34,809 Shares of Company Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) CFO Vaseem Mahboob sold 34,809 shares of the business’s stock in a transaction dated Tuesday, October 27th. The shares were sold at an average price of $30.04, for a total value of $1,045,662.36. Following the sale, the chief financial officer directly owned 60,609 shares of the company’s stock, valued at $1,820,694.36. This represents a 36.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Vaseem Mahboob also recently made the following trade(s):

• On Wednesday, October 28th, Vaseem Mahboob sold 39,903 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $30.48, for a total transaction of $1,216,243.44.
• On Thursday, October 29th, Vaseem Mahboob sold 4,788 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $30.60, for a total transaction of $146,512.80.
• On Friday, August 7th, Vaseem Mahboob sold 26,287 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $25.88, for a total transaction of $680,307.56.
• On Tuesday, August 4th, Vaseem Mahboob sold 6,995 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $24.68, for a total value of $172,636.60.
• On Monday, August 3rd, Vaseem Mahboob sold 5,391 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $23.80, for a total transaction of $128,305.80.
• On Friday, July 31st, Vaseem Mahboob sold 8,817 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.61, for a total value of $199,352.37.

Kestra Medical Technologies Price Performance

Kestra Medical Technologies stock traded up $0.74 during mid-day trading on Thursday, reaching $30.61. 470,598 shares of the company’s stock traded hands, compared to its average volume of 351,886. Kestra Medical Technologies, Ltd. has a 12-month low of $17.34 and a 12-month high of $31.04. The company has a quick ratio of 4.69, a current ratio of 4.69 and a debt-to-equity ratio of 0.33. The stock has a 50 day moving average of $26.59 and a two-hundred day moving average of $23.76. The company has a market cap of $1.82 billion, a price-to-earnings ratio of -11.46 and a beta of 0.51.

Kestra Medical Technologies (NASDAQ:KMTS) last released its earnings results on Monday, September 14th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.61) by ($0.14). Kestra Medical Technologies had a negative return on equity of 63.83% and a negative net margin of 140.43%. The firm had revenue of $30.97 million during the quarter. Equities analysts forecast that Kestra Medical Technologies, Ltd. will post -2.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on KMTS shares. BTIG Research restated a “buy” rating and set a $32.00 price objective on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Evercore initiated coverage on shares of Kestra Medical Technologies in a report on Tuesday, October 20th. They issued an “outperform” rating and a $34.00 target price for the company. Weiss Ratings upgraded shares of Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, September 16th. JPMorgan Chase & Co. assumed coverage on shares of Kestra Medical Technologies in a research report on Monday, August 10th. They issued an “overweight” rating and a $30.00 price objective on the stock. Finally, Royal Bank Of Canada set a $30.00 price objective on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $29.00.

Institutional Trading of Kestra Medical Technologies

A number of hedge funds have recently modified their holdings of the stock. Sterling Capital Management LLC lifted its stake in shares of Kestra Medical Technologies by 834.0% in the 3rd quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock valued at $25,000 after purchasing an additional 784 shares during the period. The Manufacturers Life Insurance Company grew its position in Kestra Medical Technologies by 6.6% during the first quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock valued at $1,844,000 after buying an additional 5,731 shares during the period. California State Teachers Retirement System increased its holdings in Kestra Medical Technologies by 39.2% in the first quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock valued at $555,000 after buying an additional 7,844 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in Kestra Medical Technologies in the third quarter valued at $353,000. Finally, Quantinno Capital Management LP acquired a new position in shares of Kestra Medical Technologies in the first quarter worth about $431,000.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.